Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib

Clinical trial NCT07428707 · RECRUITING

Trial details

NCT number: NCT07428707
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)

Start date: 2026-03-11
Primary completion: 2030-02-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.